Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Psychedelics Research

Recent news which mentions Psychedelics Research

< Previous 1 2 Next >
DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
Tickers NEWS
Tags Drug Enforcement Administration Controlled Substance Act Psychedelics
From Benzinga
Fed Health Agency Funds $2.4M Study On Psychedelics Treatment For Meth Addiction
Tickers NEWS
Tags Psilocybin Market News methamphetamine
From Benzinga
Podcast - Intro To A Toll-Free Psychedelics Information Line, An Educational Tool By Unlimited Sciences
Tickers NEWS
Tags Unlimited Sciences Market News Cannabis
From Benzinga
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Tickers AWKNF BETRF CMND FLHLF
Tags Psychedelics Reform Psychedelics Psychedelics Research
From Benzinga
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Tickers AGNPF ATAI CMND CMPS
Tags ENVB Benzinga Psychedelics Podcast Market News
From Benzinga
Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends
Tickers NEWS NUMIF
Tags Psychedelic/Assisted Therapies Market News Earnings
From Benzinga
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
Tickers NEWS OPTHF
Tags Cannabis Market News Global
From Benzinga
Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More
Tags Market News Cannabis FDA
From Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
Tickers AGNPF
Tags Benzinga Management AGNPF
From Benzinga
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Tickers CMND CMPS CYBN FLHLF
Tags Biotech FLHLF Psychedelics Research
From Benzinga
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Tickers ATAI CMND CMPS DRUG
Tags META Benzinga psilocybin therapies
From Benzinga
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
Tickers ATAI CMPS
Tags financial results Benzinga Psychedelics Research
From Benzinga
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
Tickers ATAI NEWS
Tags Biotech Benzinga Psychedelics Research
From Benzinga
PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
Tickers MDXXF
Tags Cannabis Biotech MDXXF
From Benzinga
Two Top Biotechs Forge MDMA Supply Deals For Clinical Research
Tickers MDXXF NEWS NUMIF OPTHF
Tags News OPTHF NUMIF
From Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
Tickers NEWS NUMIF
Tags FDA Benzinga Psychedelics Research
From Benzinga
Congress Discusses Remaining FY2024 Spending Bill With Provisions On Cannabis Sales And Psychedelic Clinical Trials
Tags Benzinga Congress Fiscal Year 2024 Legal
From Benzinga
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Tickers ATAI CMND CMPS CYBN
Tags Market News CMPS Breakthrough Therapy Drug
From Benzinga
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
Tickers ATAI BETRF CMND ENVB
Tags HUGE Market News ATAI
From Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Tickers ATAI CMND CMPS CYBN
Tags Psychedelics Research Psychedelics LSDI
From Benzinga
Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
Tickers BRAXF FLHLF OPTHF SILFF
Tags BRAXF SILFF Benzinga
From Benzinga
Beckley Academy's Open-Source Psychedelic Therapy Learning Framework Is Out: What's It All About? Authoring Team Shares Insights
Tags Psychedelics Psychedelics Research Education
From Benzinga
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
Tickers IXHL NEWS
Tags Market News Cannabis Biotech
From Benzinga
FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
Tickers JNJ MNMD
Tags Psychedelics Research Psychedelics Events
From Benzinga
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Tickers AWKNF CMND CMPS FLHLF
Tags Psychedelics Research Psychedelics Stories That Matter
From Benzinga
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
Tickers ATAI CMND CMPS CYBN
Tags Psychedelics Reform Psychedelics Psychedelics Research
From Benzinga
DEA Acknowledges Psychedelics & Cannabis Research Needs, Seeks Production Increases
Tags Psychedelics Delta/9 THC Psychedelics Research
From Benzinga
Cybin's Deuterated Psychedelics Programs Protected By Three New International Patents
Tickers CYBN DMTTF
Tags Management Legal Penny Stocks
From Benzinga
Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics
Tickers CYBN DMTTF
Tags Psychedelic/Assisted Therapies CYBN DMT Clinical Trial
From Benzinga
Harvard's New Psychedelics Research Program Backed By Former Tesla Director's $16M Donation
Tickers NFLX TSLA
Tags News Gracias Family Foundation Antonio Gracias
From Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.